Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats

No abstract is available for this paper.

• Publication year

  2006

• Venue

  British Journal of Pharmacology

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjp.0706774PMID 16715120PMCID PMC1751866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic Polypeptide-Fold Peptide Receptors and Angiotensin II–Induced Renal Vasoconstriction

  2006cited by this paper
• Hyperinnervation of Mesenteric Arteries in Spontaneously Hypertensive Rats by Sympathetic but Not Primary Afferent Axons

  2005cited by this paper
• Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague‐Dawley rats

  2005cited by this paper
• Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries

  2004cited by this paper
• Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension.

  2004cited by this paper
• The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors

  2003cited by this paper
• Enhanced Neuropeptide Y Immunoreactivity and Vasoconstriction in Mesenteric Small Arteries from Spontaneously Hypertensive Rats

  2003cited by this paper
• Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle

  2003cited by this paper
• Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist.

  2002cited by this paper
• Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.

  2002cited by this paper
• Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues.

  2002cited by this paper
• Vascular pharmacology of BIIE0246, the first selective non‐peptide neuropeptide Y Y2 receptor antagonist, in vivo

  2001cited by this paper
• The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.

  2001cited by this paper
• Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions

  2001cited by this paper
• Neuropeptide Y—Mediated Constriction and Dilation in Rat Middle Cerebral Arteries

  2001cited by this paper
• Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y1‐receptor in rat mesenteric small arteries

  2000cited by this paper
• Sympathetic activation in the pathogenesis of hypertension and progression of organ damage.

  1999cited by this paper
• Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor

  1999cited by this paper
• BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

  1999cited by this paper
• Multiple Receptors for the Pancreatic Polypeptide (PP-Fold) Family: Physiological Implications

  1998cited by this paper
• XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.

  1998influential reference
• Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor

  1998cited by this paper
• Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries.

  1998cited by this paper
• Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.

  1998cited by this paper
• Impaired function of alpha‐2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats

  1998cited by this paper
• Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential

  1997cited by this paper
• Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.

  1997cited by this paper
• BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties.

  1996cited by this paper
• Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation.

  1996influential reference
• Regional involvement of an endothelium‐derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries

  1995cited by this paper
• Increased vasopressor actions of intraventricular neuropeptide Y-(13-36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius.

  1995cited by this paper
• Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226

  1995cited by this paper
• Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.

  1993cited by this paper
• Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.

  1992cited by this paper
• Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat.

  1990cited by this paper
• Spontaneous Hypertension Is Primarily the Result of Sympathetic Overactivity and Immunologic Dysfunction

  1986cited by this paper

• Comparison of Adrenergic and Purinergic Receptor Contributions to Vasomotor Responses in Mesenteric Arteries of C57BL/6J Mice and Wistar Rats

  2020cites this paper
• Different mechanisms involved in liraglutide and glucagon‐like peptide‐1 vasodilatation in rat mesenteric small arteries

  2018cites this paper
• Genetic Programming of Hypertension

  2018cites this paper
• Neuropeptide Y-mediated sex- and afferent-specific neurotransmissions contribute to sexual dimorphism of baroreflex afferent function

  2016cites this paper
• Functional pharmacological characterization of SER100 in cardiovascular health and disease

  2016cites this paper
• Retrograde-tracing and immunohistochemical study of sympathetic ganglia to the csa rabbit model

  2016cites this paper
• Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.

  2013cites this paper
• Obesity and Appetite Control

  2012cites this paper
• Ghrelin PYY 3-36 Serum Changes in Left Ventricular Hypertrophic, Insulin-Resistant, Hypertensive Obese Patients

  2011cites this paper
• Activation of neuropeptide Y(2) receptors exerts an excitatory action on cardio-respiratory variables in anaesthetized rats.

  2011cites this paper
• NPY Y(1) receptors are involved in cardio-respiratory responses to intravenous injection of neuropeptide Y in anaesthetized rats.

  2010cites this paper
• Alterations in sympathetic neuroeffector transmission to mesenteric arteries but not veins in DOCA-salt hypertension.

  2010cites this paper
• Neuropeptide Y and neurovascular control in skeletal muscle and skin.

  2009cites this paper
• Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.

  2008cites this paper
• A new endogenous form of PYY isolated from canine ileum: Gly-extended PYY(1-36).

  2008cites this paper
• Neuropeptide Y Y2 receptor in health and disease

  2008cites this paper
• Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.

  2008cites this paper
• Y2 receptor gene variants reduce the risk of hypertension in obese children and adolescents

  2008cites this paper
• Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

  2007cites this paper
• Physiology of penile erection and pathophysiology of erectile dysfunction.

  2005cites this paper
• @Western Scholarship@Western

  year unknowncites this paper